INBX: Inhibrx Biosciences, Inc. Stock

by  •  • Comments Off on INBX: Inhibrx Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 181.82
Enterprise Value ($M) -14.51
Book Value ($M) 178.47
Book Value / Share 12.33
Price / Book 1.02
NCAV ($M) 163.35
NCAV / Share 11.28
Price / NCAV 1.11

Profitability (mra)
Return on Invested Capital (ROIC) 9.59
Return on Assets (ROA) 66.47
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.64
Current Ratio 4.70

Balance Sheet (mrq) ($M)
Current Assets 207.45
Assets 222.56
Liabilities 44.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-04 13G BlackRock, Inc.
11-14 13G Perceptive Advisors Llc 9.90 -24.39
06-07 13G Viking Global Investors Lp 12.30
06-03 13D Lappe Mark 5.26
06-03 13D Kayyem Jon Faiz 5.65
05-31 13G Sanofi 8.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 17,591 73,799 23.84
2025-02-21 8,373 52,671 15.90
2025-02-20 8,064 50,015 16.12
2025-02-19 6,555 31,695 20.68

(click for more detail)

Similar Companies
IGMS – IGM Biosciences, Inc. IMUX – Immunic, Inc.
IMVT – Immunovant, Inc. INDV – Indivior PLC
INNV – InnovAge Holding Corp.


Financial data and stock pages provided by
Fintel.io